Notice Pursuant to the National Cooperative Research and Production Act of 1993-R Consortium, Inc., 52090 [2024-13629]
Download as PDF
<![CDATA[
52090
Federal Register / Vol. 89, No. 120 / Friday, June 21, 2024 / Notices
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—The Institute of Electrical
and Electronics Engineers, Inc.
Notice is hereby given that, on April
11, 2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), The Institute of
Electrical and Electronics Engineers,
Inc. (‘‘IEEE’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing additions or
changes to its standards development
activities. The notifications were filed
for the purpose of extending the Act’s
provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, 32 new standards have
been initiated, and 3 existing standards
are being revised. More detail regarding
these changes can be found at: https://
standards.ieee.org/about/sasb/sba/
21mar2024/.
The following pre-standards activities
associated with IEEE Industry
Connections Activities were launched
or renewed: https://standards.ieee.org/
about/bog/cag/approvals/april2024/.
On September 17, 2004, the IEEE filed
its original notification pursuant to
section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to section
6(b) of the Act on November 3, 2004 (69
FR 64105).
The last notification was filed with
the Department on February 20, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on April 16, 2024 (89 FR 26922).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–13618 Filed 6–20–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
ddrumheller on DSK120RN23PROD with NOTICES1
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—R Consortium, Inc.
Notice is hereby given that, on April
22, 2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), R Consortium, Inc.
(‘‘R Consortium’’) has filed written
notifications simultaneously with the
VerDate Sep<11>2014
17:46 Jun 20, 2024
Jkt 262001
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Arcus Biosciences Inc.,
Hayward, CA; and Sanofi, Bridgewater,
NJ, have been added as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and R Consortium
intends to file additional written
notifications disclosing all changes in
membership.
On September 15, 2015, R Consortium
filed its original notification pursuant to
section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to section
6(b) of the Act on October 2, 2015 (80
FR 59815).
The last notification was filed with
the Department on January 29, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on March 13, 2024 (89 FR 18438).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–13629 Filed 6–20–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Medical Technology
Enterprise Consortium
Notice is hereby given that, on April
2, 2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Medical Technology
Enterprise Consortium (‘‘MTEC’’), has
filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, 10x National Security,
Aldie, VA; 4WEB, Inc., Frisco, TX;
Abram Scientific, Inc., South San
Francisco, CA; Admetsys Corp., Boston,
MA; Advanced RNA Vaccine
Technologies, Inc., North Bethesda, MD;
Aergility Corp., Dunnellon, FL; Airway
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
Shield S.L., Santander Cantabria, Spain;
AmacaThera, Inc., Toronto, CANADA;
Ampel LLC, Charlottesville, VA; Anthos
Group, Inc., Torrance, CA; Apos US
Management, Inc., New York, NY;
Asynchealth, Pebble Beach, CA;
Baebies, Inc., Durham, NC; Best Practice
Associates LLC dba Tria Federal,
Arlington, VA; Bio-Change, Ltd.,
Yokneam, ISRAEL; Black Fur
Biomedical, Tucson, AZ; Blue Spark
Technologies, Inc., Westlake, OH; Board
of Regents, Nevada System of Higher
Education on behalf of the University of
Nevada, Las Vegas, Las Vegas, NV;
Board of the Trustees of the Colorado
School of Mines, Golden, CO; Cadet
NM, Inc., Albuquerque, NM; Cambridge
Research & Development, Inc., Nashua,
NH; Canaery, Alachua, FL;
Coldplasmatech GmbH, Greifswald,
GERMANY; ComeBack Mobility, Inc.,
New York, NY; CoolSpine LLC,
Woodbury, CT; Cristae Consulting LLC,
Moorestown, NJ; Directed Systems, Ltd.,
Cambridge, UNITED KINGDOM;
Eluciderm, Inc., San Diego, CA; ExThera
Medical Corp., Martinez, CA; EyeYon
Medical, Ltd., Ness Ziona, ISRAEL;
Florida Institute of Technology,
Melbourne, FL; FluidForm, Inc.,
Waltham, MA; Gigantor Technologies,
Inc., Melbourne Beach, FL; Global
Virtual Training LLC, New York, NY;
GoodCap Pharmaceuticals, Toronto,
CANADA; Hatch Product Development
LLC, Waukegan, IL; Henley Ion LLC,
New Orleans, LA; Idea Meds, Inc., New
York, NY; Immense Dynamics, Inc.,
Bremerton, WA; Innovative Health
Sciences LLC, Chester, NY; Innovosens
AB, Inc., Wilmington, DE;
Interoperability Institute LLC, Lansing,
MI; JustBard Technologies LLC,
Brunswick, MD; KaloCyte, Inc.,
Baltimore, MD; LaCire LLC, Alexandria,
VA; Lankenau Institute for Medical
Research, Wynnewood, PA; Loma Linda
University, Loma Linda, CA; Lucid
Reality Labs LLC, Miami, FL; LumaFlo,
Inc., Detroit, MI; Lundquist Institute for
Medical Innovation at Harbor-UCLA
Medical Center, Torrance, CA;
Medasense Biometrics, Ltd., Ramat Gan,
ISRAEL; MediCarbone, Inc., Tuscon,
AZ; Mitochon Pharmaceuticals, Inc.,
Blue Bell, PA; Modular Matter, Inc.,
Abingdon, MD; Moonrise Medical, Inc.,
Oakville, CANADA; Noleus
Technologies, Inc., Houston, TX; Nou
Systems, Inc., Huntsville, AL; Noxy
Health Products, Inc., Anaconda, MT;
Oak Grove Technologies, Raleigh, NC;
Obsidian Solutions Group,
Fredericksburg, VA; Omniox, Inc., San
Francisco, CA; Osetomics LLC, Glen
Mills, PA; Osteolyse, Inc., Soda Springs,
CA; Owl Therapeutics, San Antonio,
E:\FR\FM\21JNN1.SGM
21JNN1
]]>Agencies
[Federal Register Volume 89, Number 120 (Friday, June 21, 2024)]
[Notices]
[Page 52090]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13629]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--R Consortium, Inc.
Notice is hereby given that, on April 22, 2024, pursuant to section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), R Consortium, Inc. (``R
Consortium'') has filed written notifications simultaneously with the
Attorney General and the Federal Trade Commission disclosing changes in
its membership. The notifications were filed for the purpose of
extending the Act's provisions limiting the recovery of antitrust
plaintiffs to actual damages under specified circumstances.
Specifically, Arcus Biosciences Inc., Hayward, CA; and Sanofi,
Bridgewater, NJ, have been added as parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and R Consortium intends to file
additional written notifications disclosing all changes in membership.
On September 15, 2015, R Consortium filed its original notification
pursuant to section 6(a) of the Act. The Department of Justice
published a notice in the Federal Register pursuant to section 6(b) of
the Act on October 2, 2015 (80 FR 59815).
The last notification was filed with the Department on January 29,
2024. A notice was published in the Federal Register pursuant to
section 6(b) of the Act on March 13, 2024 (89 FR 18438).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-13629 Filed 6-20-24; 8:45 am]
BILLING CODE P
